tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Theriva Biologics Announces At-The-Market Stock Offering
PremiumCompany AnnouncementsTheriva Biologics Announces At-The-Market Stock Offering
2M ago
Theriva Biologics Presents Promising VCN-01 Study Results
Premium
Company Announcements
Theriva Biologics Presents Promising VCN-01 Study Results
3M ago
Theriva Biologics announces presentation of data from VCN-01 Phase 1 trial
Premium
The Fly
Theriva Biologics announces presentation of data from VCN-01 Phase 1 trial
3M ago
Theriva Biologics downgraded to Hold from Buy at Maxim
PremiumThe FlyTheriva Biologics downgraded to Hold from Buy at Maxim
3M ago
Theriva Biologics prices 6.8M shares at $1.10 in public offering
Premium
The Fly
Theriva Biologics prices 6.8M shares at $1.10 in public offering
3M ago
Theriva Biologics announces primary endpoints for efficacy met in VIRAGE study
Premium
The Fly
Theriva Biologics announces primary endpoints for efficacy met in VIRAGE study
3M ago
Theriva Biologics files to sell 7.69M shares of common stock, warrants
PremiumThe FlyTheriva Biologics files to sell 7.69M shares of common stock, warrants
8M ago
Theriva Biologics Advances VCN-01 with FDA Guidance
Premium
Company Announcements
Theriva Biologics Advances VCN-01 with FDA Guidance
8M ago
Theriva Biologics announces U.S. FDA guidance of Phase 3 study design
Premium
The Fly
Theriva Biologics announces U.S. FDA guidance of Phase 3 study design
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100